Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion (Q85660596)
Jump to navigation
Jump to search
scientific article published on 01 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion |
scientific article published on 01 October 2014 |
Statements
Preclinical activity of nanoliposomal irinotecan is governed by tumor deposition and intratumor prodrug conversion (English)
Ashish V Kalra
Jaeyeon Kim
Stephan G Klinz
Nancy Paz
Jason Cain
Daryl C Drummond
Ulrik B Nielsen
Jonathan B Fitzgerald
1 October 2014